Morgan Stanley reduced its price objective, while Keefe, Bruyette & Woods increased it, as Citigroup began coverage on Lincoln International.
2 reports, 2 independent
Updated Tue 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Morgan Stanley reduced its price objective, while Keefe, Bruyette & Woods increased it, as Citigroup began coverage on Lincoln International.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Lincoln International
multinational financial services company
Nothing else this week.
-
Morgan Stanley
U.S. investment bank
-
Keefe, Bruyette & Woods
investment bank
Related events
- MarketBeat reported consensus ratings as Keefe, Bruyette & Woods dropped its target price and Citigroup reissued a market outperform rating.
- Morgan Stanley and Citigroup raised price targets on Appian Corporation, with MarketBeat aggregating the consensus data.
- Morgan Stanley and Bank of America raised price targets on NetApp shares, with MarketBeat reporting the consensus rating.
- MarketBeat aggregated consensus ratings and average price targets for Atour Lifestyle Holdings Limited. Morgan Stanley provided an overweight rating and price target.
- Citigroup, Morgan Stanley, and TD Cowen have raised their price targets and upgraded ratings for Royalty Pharma, with filings made public via the SEC.